Science
Bank of America is dropping $250+ million on GLP-1s annually
In recruiting, GLP-1 coverage could be the new unlimited PTO or wellness stipend.
Biotechnology, Pharma & Life Sciences
From breaking news to deep dives, follow the latest developments in biotechnology, pharma & life sciences with Morning Brew’s dedicated industry coverage.
Science
The GLP-1 leader expands into psychedelics
Lilly has said it would spend up to $25 billion on acquisitions this year.
Science
First human trial of reverse-aging drug begins
Don’t expect a pill to take you back to 21 any time soon.
Science
New Eli Lilly drug may be the strongest GLP-1 yet
Some of the drug's trial results were about on par with weight loss from gastric bypass surgery.
Science
Mad scientists want to bring back an extinct antelope
Gone for nearly 200 years, the bluebuck could be making a comeback
Science
mRNA vaccines could treat aggressive pancreatic cancer
The vaccine works like immunotherapy.
Science
Peptides may become easier to get this summer
The FDA will hold a meeting in July to discuss loosening restrictions on seven peptides
Become smarter in just 5 minutes
Morning Brew delivers quick and insightful updates about the business world every day of the week from Wall St. to Silicon Valley.
By subscribing, you accept our Terms & Privacy Policy.
